Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding [Yahoo! Finance]
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today [Yahoo! Finance]
Medincell to Participate in Leerink and Jefferies Miami Investor Conferences, March 8 – 11, 2026 [Yahoo! Finance]
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
????????:???????????????????2035????354.1??????? [CNET News]